Ascentage Pharma Group International - Unsponsored ADR AAPG

14.86 (0.37) (2.43%) as of 25 Sep
Market cap
$1.4B
P/E
—

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Jun '26 Dec '25 Jun '25 Dec '24 Older periods
Net Income
0.00 (176.75) 0.00 (54.15)

+2 more quarters

Depreciation & Amortization
— 10.84 — 11.24
Other operating activities
— 18.53 — 12.45
Operating Cash Flow
(85.66) (167.90) — (15.26)
Capital expenditures
(1.75) (3.94) — (3.33)
Net Aquisitions
— 0.00 — 0.00
Long-Term Investments Change (Net)
(0.44) — — —
Other investing activities
139.32 (138.49) — (44.08)
Investing cash flow
137.13 (143.01) — (49.60)
Repayment/Issuance of Debt (Net)
15.85 0.00 — 0.00
Equity Repurchase (Common, Net)
(1.15) — — —
Dividends Paid (Total)
— 0.00 — 0.00
Other financial activities
(3.84) (9.01) — (10.12)
Financing cash flow
10.86 363.23 — 43.12
Exchange Rate Adjustment
(7.60) (9.04) — 1.88
Change in Cash
54.73 43.28 — (19.86)
Beginning Cash
176.24 127.71 — 142.21
Ending Cash
230.97 171.00 — 122.35
Dividends Paid (Common)
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
— (20.52) — 15.20
Investments Change (Net)
(0.44) (0.57) — (2.19)
Issuance/Purchase of Shares
(1.15) 328.31 — 73.15

Fold the line items

In millions of $ except per-share values · columns are period end dates